Linked Life Data

2457584

Source:http://linkedlifedata.com/resource/pubmed/id/2457584

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2457584rdf:typepubmed:Citationlld:pubmed
pubmed-article:2457584lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:2457584lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:2457584lifeskim:mentionsumls-concept:C0080103lld:lifeskim
pubmed-article:2457584lifeskim:mentionsumls-concept:C0009015lld:lifeskim
pubmed-article:2457584lifeskim:mentionsumls-concept:C0042971lld:lifeskim
pubmed-article:2457584lifeskim:mentionsumls-concept:C1136310lld:lifeskim
pubmed-article:2457584lifeskim:mentionsumls-concept:C0017968lld:lifeskim
pubmed-article:2457584lifeskim:mentionsumls-concept:C0021701lld:lifeskim
pubmed-article:2457584lifeskim:mentionsumls-concept:C0017963lld:lifeskim
pubmed-article:2457584lifeskim:mentionsumls-concept:C0034793lld:lifeskim
pubmed-article:2457584lifeskim:mentionsumls-concept:C1334146lld:lifeskim
pubmed-article:2457584lifeskim:mentionsumls-concept:C1366562lld:lifeskim
pubmed-article:2457584lifeskim:mentionsumls-concept:C1706439lld:lifeskim
pubmed-article:2457584lifeskim:mentionsumls-concept:C0033453lld:lifeskim
pubmed-article:2457584lifeskim:mentionsumls-concept:C1154393lld:lifeskim
pubmed-article:2457584lifeskim:mentionsumls-concept:C0678594lld:lifeskim
pubmed-article:2457584lifeskim:mentionsumls-concept:C0205225lld:lifeskim
pubmed-article:2457584lifeskim:mentionsumls-concept:C1321758lld:lifeskim
pubmed-article:2457584pubmed:issue25lld:pubmed
pubmed-article:2457584pubmed:dateCreated1988-9-28lld:pubmed
pubmed-article:2457584pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2457584pubmed:abstractTextMac-1 (CD 11b/CD18) is a leukocyte adhesion heterodimeric glycoprotein which functions both as a receptor for iC3b (CR3) and in several cell-cell and cell-substrate adhesive interactions. We describe full-length cDNA clones for the alpha subunit of Mac-1. Mac-1 alpha subunit message was detected in blood monocytes and phorbol-12-myristate acetate-induced myeloid cell lines, but not in cells of the T or B lineages, correlating with Mac-1 protein surface expression. The alpha subunit of Mac-1 is a transmembrane protein of 1137 residues with a long extracellular domain (1092 residues) and a 19-amino acid cytoplasmic tail. The extracellular domain contains three putative divalent cation-binding sequences and 19 potential N-glycosylation sites. The amino acid sequence of Mac-1 alpha shows that it is a member of the integrin superfamily; Mac-1 alpha shows 63% identity to the alpha subunit of the leukocyte adhesion glycoprotein p150.95 and 25% to the alpha subunits of the extracellular matrix receptors platelet glycoprotein IIb/IIIa, the fibronectin receptor, and the vitronectin receptor. The Mac-1 alpha subunit putative divalent cation-binding sites and the flanking regions exhibit a high degree of identity both to the p150.95 alpha subunit (87% identity at the amino acid level) and to the rest of the integrin alpha subunits (38%). The alpha subunit of Mac-1, like the p150.95 alpha subunit, contains a domain of 187 amino acids in the extracellular region which is absent in other integrins. This leukocyte or "L" domain is homologous to the A domains of von Willebrand factor, which in turn are homologous to regions of the C3-binding proteins factor B and C2. These findings draw attention to this region of Mac-1 as a potential binding site for iC3b.lld:pubmed
pubmed-article:2457584pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2457584pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2457584pubmed:languageenglld:pubmed
pubmed-article:2457584pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2457584pubmed:citationSubsetIMlld:pubmed
pubmed-article:2457584pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2457584pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2457584pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2457584pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2457584pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2457584pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2457584pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2457584pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2457584pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2457584pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2457584pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2457584pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2457584pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2457584pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2457584pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2457584pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2457584pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2457584pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2457584pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2457584pubmed:statusMEDLINElld:pubmed
pubmed-article:2457584pubmed:monthSeplld:pubmed
pubmed-article:2457584pubmed:issn0021-9258lld:pubmed
pubmed-article:2457584pubmed:authorpubmed-author:MillerL JLJlld:pubmed
pubmed-article:2457584pubmed:authorpubmed-author:SpringerT ATAlld:pubmed
pubmed-article:2457584pubmed:authorpubmed-author:KishimotoT...lld:pubmed
pubmed-article:2457584pubmed:authorpubmed-author:CorbiA LALlld:pubmed
pubmed-article:2457584pubmed:issnTypePrintlld:pubmed
pubmed-article:2457584pubmed:day5lld:pubmed
pubmed-article:2457584pubmed:volume263lld:pubmed
pubmed-article:2457584pubmed:ownerNLMlld:pubmed
pubmed-article:2457584pubmed:authorsCompleteYlld:pubmed
pubmed-article:2457584pubmed:pagination12403-11lld:pubmed
pubmed-article:2457584pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:2457584pubmed:meshHeadingpubmed-meshheading:2457584-...lld:pubmed
pubmed-article:2457584pubmed:meshHeadingpubmed-meshheading:2457584-...lld:pubmed
pubmed-article:2457584pubmed:meshHeadingpubmed-meshheading:2457584-...lld:pubmed
pubmed-article:2457584pubmed:meshHeadingpubmed-meshheading:2457584-...lld:pubmed
pubmed-article:2457584pubmed:meshHeadingpubmed-meshheading:2457584-...lld:pubmed
pubmed-article:2457584pubmed:meshHeadingpubmed-meshheading:2457584-...lld:pubmed
pubmed-article:2457584pubmed:meshHeadingpubmed-meshheading:2457584-...lld:pubmed
pubmed-article:2457584pubmed:meshHeadingpubmed-meshheading:2457584-...lld:pubmed
pubmed-article:2457584pubmed:meshHeadingpubmed-meshheading:2457584-...lld:pubmed
pubmed-article:2457584pubmed:meshHeadingpubmed-meshheading:2457584-...lld:pubmed
pubmed-article:2457584pubmed:meshHeadingpubmed-meshheading:2457584-...lld:pubmed
pubmed-article:2457584pubmed:meshHeadingpubmed-meshheading:2457584-...lld:pubmed
pubmed-article:2457584pubmed:meshHeadingpubmed-meshheading:2457584-...lld:pubmed
pubmed-article:2457584pubmed:meshHeadingpubmed-meshheading:2457584-...lld:pubmed
pubmed-article:2457584pubmed:meshHeadingpubmed-meshheading:2457584-...lld:pubmed
pubmed-article:2457584pubmed:meshHeadingpubmed-meshheading:2457584-...lld:pubmed
pubmed-article:2457584pubmed:meshHeadingpubmed-meshheading:2457584-...lld:pubmed
pubmed-article:2457584pubmed:meshHeadingpubmed-meshheading:2457584-...lld:pubmed
pubmed-article:2457584pubmed:meshHeadingpubmed-meshheading:2457584-...lld:pubmed
pubmed-article:2457584pubmed:meshHeadingpubmed-meshheading:2457584-...lld:pubmed
pubmed-article:2457584pubmed:meshHeadingpubmed-meshheading:2457584-...lld:pubmed
pubmed-article:2457584pubmed:meshHeadingpubmed-meshheading:2457584-...lld:pubmed
pubmed-article:2457584pubmed:meshHeadingpubmed-meshheading:2457584-...lld:pubmed
pubmed-article:2457584pubmed:meshHeadingpubmed-meshheading:2457584-...lld:pubmed
pubmed-article:2457584pubmed:meshHeadingpubmed-meshheading:2457584-...lld:pubmed
pubmed-article:2457584pubmed:meshHeadingpubmed-meshheading:2457584-...lld:pubmed
pubmed-article:2457584pubmed:meshHeadingpubmed-meshheading:2457584-...lld:pubmed
pubmed-article:2457584pubmed:year1988lld:pubmed
pubmed-article:2457584pubmed:articleTitleThe human leukocyte adhesion glycoprotein Mac-1 (complement receptor type 3, CD11b) alpha subunit. Cloning, primary structure, and relation to the integrins, von Willebrand factor and factor B.lld:pubmed
pubmed-article:2457584pubmed:affiliationLaboratory of Membrane Immunochemistry, Dana-Farber Cancer Institute, Boston, Massachusetts 02115.lld:pubmed
pubmed-article:2457584pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2457584pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:2457584pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:2457584pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:3684entrezgene:pubmedpubmed-article:2457584lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2457584lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2457584lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2457584lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2457584lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2457584lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2457584lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2457584lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2457584lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2457584lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2457584lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2457584lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2457584lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2457584lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2457584lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2457584lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2457584lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2457584lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2457584lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2457584lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2457584lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2457584lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2457584lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2457584lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2457584lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2457584lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2457584lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2457584lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2457584lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2457584lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2457584lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2457584lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2457584lld:pubmed
More...